Next-Generation Embolic Particles and Systems

The present inventive concept relates to a family of next-generation embolic particles and systems that offer enhanced capabilities, flexibility, and precision for occluding vascular defects and luminal defects, building upon the foundational concept of embolic particles with adaptable diameters.

The original patent disclosed embolic particles with adaptable diameters, but these particles had limitations in terms of their material properties, delivery methods, and retrievability. The new inventive concept addresses these limitations by introducing advanced materials, shape-memory properties, and external control mechanisms, enabling more effective and minimally invasive treatments for a broader range of vascular and luminal defects.

The inventive concept encompasses four primary embodiments: shape-memory embolic particles that change shape in response to a predetermined temperature; bio-absorbable embolic particles designed to dissolve over a predetermined period of time; magnetically-responsive embolic particles that can be manipulated using an external magnetic field; and light-activated embolic particles that can be expanded using a predetermined wavelength of light. These particles can be delivered through microcatheters and are configured to expand to a larger diameter upon implantation, allowing for temporary or permanent occlusion of vascular and luminal defects. The inventive concept also includes methods for treating aneurysms and occluding luminal defects using these advanced embolic particles.

The new claims introduce a paradigm shift in embolic particle technology by incorporating advanced materials and external control mechanisms, enabling a new level of precision, flexibility, and retrievability. The inventive concept's novelty lies in the combination of shape-memory, bio-absorbable, magnetically-responsive, and light-activated properties, which overcome the limitations of the original patent and provide a more comprehensive solution for occluding vascular and luminal defects.

Alternative embodiments of the inventive concept could include the use of different materials, such as polymers or metals, to create the embolic particles. Variations could also include different delivery methods, such as using a guidewire or a balloon catheter, or incorporating additional features, such as sensors or imaging agents, to enhance the particles' functionality and visibility.

The next-generation embolic particles and systems have significant commercial potential in the medical device industry, particularly in the fields of interventional radiology and vascular surgery. The inventive concept's enhanced capabilities and flexibility make it an attractive solution for treating a wide range of vascular and luminal defects, offering a competitive advantage in the market and potential for significant revenue growth.